方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 自适应随机临床试验× | 贝叶斯随机对照试验× | |
|---|---|---|
| 领域 | 流行病学 | 流行病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | Late 1990s–2000s (widespread adoption post-2010) | 1980s–2000s (formal methodology consolidated ~2004–2006) |
| 提出者≠ | Donald Berry and colleagues; formalized by FDA guidance in 2010 and 2019 | Donald A. Berry and David J. Spiegelhalter (applied Bayesian inference formally to RCT design) |
| 类型≠ | Experimental clinical trial design | Randomized experimental study with Bayesian inference |
| 开创性文献≠ | Berry, D. A. (2006). Bayesian clinical trials. Nature Reviews Drug Discovery, 5(1), 27–36. DOI ↗ | Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2004). Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Wiley. ISBN: 978-0471499756 |
| 别名 | adaptive RCT, adaptive trial design, response-adaptive randomization trial, adaptive clinical trial | Bayesian RCT, Bayesian adaptive trial, Bayesian clinical trial design, BRCT |
| 相关≠ | 6 | 5 |
| 摘要≠ | An adaptive randomized clinical trial (adaptive RCT) is a prospective experimental study that uses pre-specified rules to modify one or more trial aspects — such as sample size, allocation ratios, or treatment arms — based on accumulating data collected during the trial itself, while maintaining statistical validity and integrity of the study. | A Bayesian randomized clinical trial (Bayesian RCT) combines the rigour of random treatment allocation with Bayesian statistical inference, allowing researchers to incorporate prior evidence and update beliefs continuously as trial data accumulate. Unlike the classical frequentist RCT, it yields direct probability statements about treatment effects and supports pre-specified adaptive stopping rules based on posterior probabilities. |
| ScholarGate数据集 ↗ |
|
|